Reports Consulting Insights
All Industries Aerospace & Defense Agriculture Automotive Banking & Finance Chemicals Construction Consumer Goods Energy & Power Food & Beverages Healthcare Information Technology Manufacturing Mining & Metals Pharmaceuticals Real Estate Semiconductors Telecommunications Transportation Other
Press Releases Methodology About Us Contact Us
Download Updated Sample
Home Reports Healthcare MHC-Peptide Tetramer Market, Global Outl...
Healthcare Global

MHC-Peptide Tetramer Market, Global Outlook and Forecast 2025-2031

The global MHC-Peptide Tetramer market was valued at 178 million in 2024 and is projected to reach US$ 366 million by 2031, at a CAGR of 11.4% during the forecast period. An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex ...

May 2025
Published
The global MHC-Peptide Tetramer market was valued at 178 million in 2024 and is projected to reach US$ 366 million by 2031, at a CAGR of 11.4% during the forecast period. An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research. Increased focus on cancer immunotherapy and adoptive T cell therapies is driving demand for MHC tetramers to study antigen-specific T cell responses. Prospect Research Reports (PRR) has surveyed the MHC-Peptide Tetramer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks This report aims to provide a comprehensive presentation of the global market for MHC-Peptide Tetramer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MHC-Peptide Tetramer. This report contains market size and forecasts of MHC-Peptide Tetramer in global, including the following market information: Global MHC-Peptide Tetramer market revenue, 2020-2025, 2026-2031, ($ millions) Global top five MHC-Peptide Tetramer companies in 2024 (%) Total Market by Segment: Global MHC-Peptide Tetramer market, by Type, 2020-2025, 2026-2031 ($ millions) Global MHC-Peptide Tetramer market segment percentages, by Type, 2024 (%) MHC-I MHC-II Global MHC-Peptide Tetramer market, by Application, 2020-2025, 2026-2031 ($ millions) Global MHC-Peptide Tetramer market segment percentages, by Application, 2024 (%) Infectious Disease Research Cancer Immunology Other Global MHC-Peptide Tetramer market, by region and country, 2020-2025, 2026-2031 ($ millions) Global MHC-Peptide Tetramer market segment percentages, by region and country, 2024 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies MHC-Peptide Tetramer revenues in global market, 2020-2025 (estimated), ($ millions) Key companies MHC-Peptide Tetramer revenues share in global market, 2024 (%) Further, the report presents profiles of competitors in the market, key players include: BioLegend (Revvity) MBL Life Science (JSR Corporation) ImmunAware ProImmune MedChemExpress (MCE) Creative Biolabs WuXi AppTec KACTUS Creative Biosciences ACROBiosystems ChemPartner Outline of Major Chapters: Chapter 1: Introduces the definition of MHC-Peptide Tetramer, market overview. Chapter 2: Global MHC-Peptide Tetramer market size in revenue. Chapter 3: Detailed analysis of MHC-Peptide Tetramer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of MHC-Peptide Tetramer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
Report Chapters 9 chapters
01 Introduction to Research & Analysis Reports
02 Global MHC-Peptide Tetramer Overall Market Size
03 Company Landscape
04 Sights by Product
05 Sights by Application
06 Sights by Region
07 Companies Profiles
08 Conclusion
09 Appendix
Delivery Format
PDF + Excel
Primary Research
Expert interviews, executive surveys, and industry consultations with domain specialists.
Secondary Research
SEC filings, central bank data, regulatory publications, trade journals, and academic research.
Data Validation
Triangulation across multiple independent sources with expert review and cross-verification.
Forecast Model
Bottom-up and top-down hybrid model with scenario analysis and sensitivity testing.
Select License Type
Single User
1 user · PDF delivery
$2,999
Corporate
Up to 10 users
$4,999
Enterprise
Unlimited users
$7,999
Buy This Report

Report delivered via email · Secure payment

Get This Report
Ready to access the full analysis?
Report Details
Published May 2025
Industry Healthcare
Region Global
Format PDF + Excel